MANUSCRIPT CITATION Gupta S, Subhedar NV, Bell JL, et al. Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen. N Engl J Med. 2024;390(4):314-325. doi:10.1056/NEJMoa2305582. PMID: 38265644 Reviewed By Dr. Rashida Javed(1), Dr. Harsha Gowda(2) (1) Neonatal intensive care unit, University Hospitals Leicester, Leicester, UK (2) Neonatal intensive care unit, University Hospitals Birmingham, Birmingham, UK Corresponding author: R Javed, Neonatal intensive care unit, Leicester Royal Infirmary Hospital, LE1 5WW, UK. Email: rashida.javed@nhs.net TYPE OF INVESTIGATION ..read more

Manuscript citation Motojima Y, Nishimura E, Kabe K, Namba F. Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan. J Perinatol 2023; 43(11):1385-1391. PMID: 37393397 Reviewed by Reviewed by: Vonita Chawla MD Assistant Professor Department of Pediatrics – Division of Neonatology University of Arkansas for Medical Sciences / Arkansas Children’s Hospital Corresponding author Vonita Chawla MD chawlavonita@uams.edu Phone: 501-364-1028 Address: #1 Children’s Way, Slot 512-5, Little Rock, AR 72202, United States Type of Inve ..read more

MANUSCRIPT CITATION Kidman AM, Manley BJ, Boland RA, et al. Higher versus lower nasal continuous positive airway pressure for extubation of extremely preterm infants in Australia (ÉCLAT): a multicentre, randomised, superiority trial. October 2023,26. https://doi.org/10.1016/S2352-4642(23)00235-3 REVIEWED BY: Dr. Rashida Javed, Dr. Harsha Gowda Neonatal intensive care unit, University Hospitals Birmingham, Birmingham, UK Corresponding author: R Javed, Neonatal intensive care unit, Birmingham Heartlands Hospital, B9 5SS, UK. TYPE OF INVESTIGATION Treatment QUESTION In extreme preterm infants < ..read more

TITLE OF WRITE-UP De-MIST-ifying the two-year outcomes of non-invasive surfactant therapy MANUSCRIPT CITATION Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, et al. Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants. Follow-Up of the OPTIMIST-A Randomized Clinical Trial. JAMA 2023; 330:1054-63. PMID 37695601. REVIEWED BY Lucy Loft MBBS Neonatology, The Royal Women’s Hospital, Melbourne, Australia Email: lucy.loft@thewomens.org.au Kristin N Ferguson MBBS Neonatal Research, Murdoch Children’s Research Institute, Melbourne, Australia Neona ..read more

EBNEO Commentary: Umbrella Review Evaluating Interventions to Decrease Risk of Bronchopulmonary Dysplasia in Preterm Neonates MANUSCRIPT CITATION Abiramalatha T, Ramaswamy VV, Bandyopadhyay T, Somanath SH, Shaik NB, Pullattayil AK, Weiner GM. Interventions to Prevent Bronchopulmonary Dysplasia in Preterm Neonates: An Umbrella Review of Systematic Reviews and Meta-analyses. JAMA Pediatrics 2022; 176:502-516. PMID 35226067. REVIEWED BY Sara Stucker, MD Neonatal-Perinatal Medicine Fellow University of Minnesota Stuck085@umn.edu Ellen Diego, MD Assistant Professor of Pediatrics University of Minne ..read more

EBNEO Commentary: Early Human Milk Fortification in Infants Born Extremely Preterm: A Randomized Trial REVIEWED BY Hee Siong How, MBBS, BMedSc Monash Children’s Hospital, Melbourne, Australia Eugene.how@monashhealth.org Atul Malhotra, MD, PhD Department of Paediatrics Monash University, Melbourne, Australia atul.malhotra@monash.edu Camilia Martin, MD, MS Department of Pediatrics Cornell University, NY, USA camilia.martin@med.cornell.edu MANUSCRIPT CITATION Salas AA, Gunawan E, Nguyen K, Reeves A, Argent V, Finck A, Carlo WA. Early Human Milk Fortification in Infants Born Extremely Preterm: A R ..read more

MANUSCRIPT CITATION Oliphant EA, McKinlay CJ, McNamara D, Cavadino A, Alsweiler JM. Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial. Arch Dis Child Fetal Neonatal Ed. 2023 Mar;108(2):106-113. doi: 10.1136/archdischild-2022-324010. Epub 2022 Aug 29. PMID: 36038256 Reviewed by Ayat Mohamed, MBBS, MRCPCH Paediatric trainee ST5 Department of Neonatology Newcross Hospital Wolverhampton, United Kingdom Ayat.mohamed@nhs.net Hassanein Moustafa, MBBCh, MSc (Paed), MRCPCH Senior Clinical Fellow in neonates Department of neonatology New cross Hospit ..read more

MANUSCRIPT CITATION Madhi SA, Anderson AS, Absalon J, Radley D, Simon R, Jongihlati B, Strehlau R, van Niekerk AM, Izu A, Naidoo N, Kwatra G, Ramsamy Y, Said M, Jones S, Jose L, Fairlie L, Barnabas SL, Newton R, Munson S, Jefferies Z, Pavliakova D, Silmon de Monerri NC, Gomme E, Perez JL, Scott DA, Gruber WC, Jansen KU. Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. N Engl J Med. 2023 Jul 20;389(3):215-227. doi: 10.1056/NEJMoa2116045. PMID: 37467497. REVIEWED BY Dustin Daniel Flannery, DO, MSCE Assistant Professor of Pediatrics Children’s Hospital of Philadelph ..read more

EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD? Manuscript Citation Gentle SJ, Rysavy MA, Li L, et al. Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023;6(5):e2315315. doi:10.1001/jamanetworkopen.2023.15315. PMID 37256621 Reviewed By Timothy D. Nelin, MD Children ..read more

EBNEO Commentary: Respiratory syncytial virus vaccine in pregnancy for infant protection MANUSCRIPT CITATION Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Duron Padilla M, Richmond PC, Koury K, Schneider K, Kalinina EV, Cooper D, Jansen KU, Anderson AS, Swanson KA, Gruber WC, Gurtman A; MATISSE Study Group. Bivalent Pre ..read more